In addition to the previous finding, we described that IL-17A levels were elevated among all patients on methimazole; however, it was only significant in the active TED group, possibly reflecting a relationship with the active inflammatory phase of both hyperthyroidism and TED or perhaps a stimulatory effect of methimazole itself on IL-17. This evidence concerns the gene IL17A and hyperthyroidism.